FOURIER

A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination With Statin Therapy in Patients with CAD

Stage
klaar
Medicine
AMG 145
Population
ASCVD
Phase
III
First Patient In
15 February 2013
Last Patient In
15 March 2015
Last Patient Last Visit
4 November 2016

Study Director

dr. A.H. Liem

Cardioloog

The page has expired.